HIV-1 proteins preferentially activate anti-inflammatory m2-type macrophages

Journal of Immunology

Volumn 188, Issue 8, 2012, Pages 3620-3627

  Chihara, Takashi ^a   Hashimoto, Michihiro ^a   Osman, Abu ^a   Hiyoshi Yoshidomi, Yuka ^a   Suzu, Ikuko ^a   Chutiwitoonchai, Nopporn ^a   Hiyoshi, Masateru ^a   Okada, Seiji ^a   Suzu, Shinya ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CYTOKINE; GLYCOPROTEIN GP 120; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NEF PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY M2 TYPE MACROPHAGE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNALIZATION; MACROPHAGE; MACROPHAGE ACTIVATION; MYRISTYLATION; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROINFLAMMATORY M1 TYPE MACROPHAGE; PROTEIN MOTIF; SIGNAL TRANSDUCTION;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NF-KAPPA B; ORGAN SPECIFICITY; PHENOTYPE; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84860342686     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101593     Document Type: Article

References (66)

1. Deeks, S. G., and B. D. Walker. 2004. The immune response to AIDS virus infection: good, bad, or both? J. Clin. Invest. 113: 808-810. (Pubitemid 38544138)
2. Appay, V., and D. Sauce. 2008. Immune activation and inflammation in HIV-1 infection: causes and consequences. J. Pathol. 214: 231-241. (Pubitemid 351160160)
3. Kedzierska, K., and S. M. Crowe. 2001. Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12: 133-150. (Pubitemid 32963913)
4. Porcheray, F., B. Samah, C. Léone, N. Dereuddre-Bosquet, and G. Gras. 2006. Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Virology 349: 112-120. (Pubitemid 43732479)
5. Brown, J. N., J. J. Kohler, C. R. Coberley, J. W. Sleasman, and M. M. Goodenow. 2008. HIV-1 activates macrophages independent of Toll-like receptors. PLoS ONE 3: e3664.
6. Cassol, E., L. Cassetta, M. Alfano, and G. Poli. 2010. Macrophage polarization and HIV-1 infection. J. Leukoc. Biol. 87: 599-608.
7. Pollard, J. W. 2009. Trophic macrophages in development and disease. Nat. Rev. Immunol. 9: 259-270.
8. Mantovani, A., and A. Sica. 2010. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22: 231-237.
9. Suzu, S., H. Harada, T. Matsumoto, and S. Okada. 2005. HIV-1 Nef interferes with M-CSF receptor signaling through Hck activation and inhibits M-CSF bioactivities. Blood 105: 3230-3237.
10. Hiyoshi, M., S. Suzu, Y. Yoshidomi, R. Hassan, H. Harada, N. Sakashita, H. Akari, K. Motoyoshi, and S. Okada. 2008. Interaction between Hck and HIV1 Nef negatively regulates cell surface expression of M-CSF receptor. Blood 111: 243-250.
11. Hassan, R., S. Suzu, M. Hiyoshi, N. Takahashi-Makise, T. Ueno, T. Agatsuma, H. Akari, J. Komano, Y. Takebe, K. Motoyoshi, and S. Okada. 2009. Dysregulated activation of a Src tyroine kinase Hck at the Golgi disturbs Nglycosylation of a cytokine receptor Fms. J. Cell. Physiol. 221: 458-468.
12. Hiyoshi, M., N. Takahashi-Makise, Y. Yoshidomi, N. Chutiwitoonchai, T. Chihara, M. Okada, N. Nakamura, S. Okada, and S. Suzu. 2011. HIV-1 Nef perturbs the function, structure, and signaling of the golgi through the Src kinase Hck. J. Cell. Physiol.
13. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565. (Pubitemid 38437450)
14. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311. (Pubitemid 44715100)
15. Fleetwood, A. J., T. Lawrence, J. A. Hamilton, and A. D. Cook. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSFdependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178: 5245-5252. (Pubitemid 46595309)
16. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8: 533-544. (Pubitemid 351913679)
17. Herbein, G., G. Gras, K. A. Khan, and W. Abbas. 2010. Macrophage signaling in HIV-1 infection. Retrovirology 7: 34.
18. Del Corno, M., Q. H. Liu, D. Schols, E. de Clercq, S. Gessani, B. D. Freedman, and R. G. Collman. 2001. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calciumdependent, pertussis toxin-insensitive chemokine receptor signaling. Blood 98: 2909-2916.
19. Tomkowicz, B., C. Lee, V. Ravyn, R. Cheung, A. Ptasznik, and R. G. Collman. 2006. The Src kinase Lyn is required for CCR5 signaling in response to MIP-1β and R5 HIV-1 gp120 in human macrophages. Blood 108: 1145-1150. (Pubitemid 44232008)
20. Cheung, R., V. Ravyn, L. Wang, A. Ptasznik, and R. G. Collman. 2008. Signaling mechanism of HIV-1 gp120 and virion-induced IL-1β release in primary human macrophages. J. Immunol. 180: 6675-6684.
21. Lafrenie, R. M., L. M. Wahl, J. S. Epstein, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 1996. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J. Immunol. 157: 974-977.
22. Kumar, A., S. K. Manna, S. Dhawan, and B. B. Aggarwal. 1998. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161: 776-781. (Pubitemid 28323541)
23. Gee, K., J. B. Angel, S. Mishra, M. A. Blahoianu, and A. Kumar. 2007. IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J. Immunol. 178: 798-807. (Pubitemid 46095152)
24. Federico, M., Z. Percario, E. Olivetta, G. Fiorucci, C. Muratori, A. Micheli, G. Romeo, and E. Affabris. 2001. HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood 98: 2752-2761.
25. Varin, A., S. K. Manna, V. Quivy, A. Z. Decrion, C. Van Lint, G. Herbein, and B. B. Aggarwal. 2003. Exogenous Nef protein activates NF-κ B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis. J. Biol. Chem. 278: 2219-2227. (Pubitemid 36801289)
26. Mangino, G., Z. A. Percario, G. Fiorucci, G. Vaccari, S. Manrique, G. Romeo, M. Federico, M. Geyer, and E. Affabris. 2007. In vitro treatment of human monocytes/macrophages with myristoylated recombinant Nef of human immunodeficiency virus type 1 leads to the activation of mitogen-activated protein kinases, IkappaB kinases, and interferon regulatory factor 3 and to the release of beta interferon. J. Virol. 81: 2777-2791. (Pubitemid 46447042)
27. Olivetta, E., Z. Percario, G. Fiorucci, G. Mattia, I. Schiavoni, C. Dennis, J. Jäger, M. Harris, G. Romeo, E. Affabris, and M. Federico. 2003. HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-κ B activation. J. Immunol. 170: 1716-1727. (Pubitemid 36197386)
28. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67: 277-287. (Pubitemid 23002988)
29. + T cells. FEBS Lett. 393: 93-96. (Pubitemid 26298237)
30. Ryan, G. R., X. M. Dai, M. G. Dominguez, W. Tong, F. Chuan, O. Chisholm, R. G. Russell, J. W. Pollard, and E. R. Stanley. 2001. Rescue of the colonystimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 98: 74-84.
31. Dai, X. M., G. R. Ryan, A. J. Hapel, M. G. Dominguez, R. G. Russell, S. Kapp, V. Sylvestre, and E. R. Stanley. 2002. Targeted disruption of the mouse colonystimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99: 111-120.
32. Suzu, S., F. Kimura, J. Ota, K. Motoyoshi, T. Itoh, Y. Mishima, M. Yamada, and S. Shimamura. 1997. Biologic activity of proteoglycan macrophage colonystimulating factor. J. Immunol. 159: 1860-1867. (Pubitemid 127484174)
33. Qiao, X., B. He, A. Chiu, D. M. Knowles, A. Chadburn, and A. Cerutti. 2006. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 7: 302-310.
34. Prost, S., M. Le Dantec, S. Augé, R. Le Grand, S. Derdouch, G. Auregan, N. Déglon, F. Relouzat, A. M. Aubertin, B. Maillere, et al. 2008. Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/ PPARgamma/STAT5 signaling pathway in macaques. J. Clin. Invest. 118: 1765-1775. (Pubitemid 351632379)
35. Chihara, T., S. Suzu, R. Hassan, N. Chutiwitoonchai, M. Hiyoshi, K. Motoyoshi, F. Kimura, and S. Okada. 2010. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 17: 1917-1927.
36. Akagawa, K. S. 2002. Functional heterogeneity of colony-stimulating factorinduced human monocyte-derived macrophages. Int. J. Hematol. 76: 27-34. (Pubitemid 43020277)
37. dok-2 as a cytokine-inducible inhibitor of cell proliferation and signal transduction. EMBO J. 19: 5114-5122.
38. Suzu, S., M. Hiyoshi, Y. Yoshidomi, H. Harada, M. Takeya, F. Kimura, K. Motoyoshi, and S. Okada. 2007. M-CSF-mediated macrophage differentiation but not proliferation is correlated with increased and prolonged ERK activation. J. Cell. Physiol. 212: 519-525. (Pubitemid 47025642)
39. Hashimoto, S., T. Suzuki, H. Y. Dong, N. Yamazaki, and K. Matsushima. 1999. Serial analysis of gene expression in human monocytes and macrophages. Blood 94: 837-844. (Pubitemid 29361813)
40. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a doubleedged sword. Nat. Rev. Immunol. 3: 745-756. (Pubitemid 41070815)
41. Alessandrini, L., A. C. Santarcangelo, E. Olivetta, F. Ferrantelli, P. d'Aloja, K. Pugliese, E. Pelosi, C. Chelucci, G. Mattia, C. Peschle, et al. 2000. T-tropic human immunodeficiency virus (HIV) type 1 Nef protein enters human monocyte-macrophages and induces resistance to HIV replication: a possible mechanism of HIV T-tropic emergence in AIDS. J. Gen. Virol. 81: 2905-2917. (Pubitemid 32000638)
42. Quaranta, M. G., B. Mattioli, F. Spadaro, E. Straface, L. Giordani, C. Ramoni, W. Malorni, and M. Viora. 2003. HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 17: 2025-2036. (Pubitemid 37392447)
43. Fackler, O. T., and A. S. Baur. 2002. Live and let die: Nef functions beyond HIV replication. Immunity 16: 493-497. (Pubitemid 34442574)
44. Peterlin, B. M., and D. Trono. 2003. Hide, shield and strike back: how HIVinfected cells avoid immune eradication. Nat. Rev. Immunol. 3: 97-107. (Pubitemid 37328688)
45. Foster, J. L., and J. V. Garcia. 2008. HIV-1 Nef: at the crossroads. Retrovirology 5: 84.
46. Malim, M. H., and M. Emerman. 2008. HIV-1 accessory proteins - ensuring viral survival in a hostile environment. Cell Host Microbe 3: 388-398. (Pubitemid 351784365)
47. + viruses but not for down-regulation of CD4. EMBO J. 14: 484-491.
48. Moarefi, I., M. LaFevre-Bernt, F. Sicheri, M. Huse, C. H. Lee, J. Kuriyan, and W. T. Miller. 1997. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385: 650-653. (Pubitemid 27087580)
49. Lerner, E. C., and T. E. Smithgall. 2002. SH3-dependent stimulation of Srcfamily kinase autophosphorylation without tail release from the SH2 domain in vivo. Nat. Struct. Biol. 9: 365-369. (Pubitemid 34462555)
50. Deacon, S. W., A. Beeser, J. A. Fukui, U. E. Rennefahrt, C. Myers, J. Chernoff, and J. R. Peterson. 2008. An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem. Biol. 15: 322-331. (Pubitemid 351508427)
51. Verreck, F. A., T. de Boer, D. M. Langenberg, L. van der Zanden, and T. H. Ottenhoff. 2006. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulation. J. Leukoc. Biol. 79: 285-293. (Pubitemid 44831160)
52. Komohara, Y., J. Hirahara, T. Horikawa, K. Kawamura, E. Kiyota, N. Sakashita, N. Araki, and M. Takeya. 2006. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J. Histochem. Cytochem. 54: 763-771. (Pubitemid 43946243)
53. Nilsson, S. K., G. J. Lieschke, C. C. Garcia-Wijnen, B. Williams, D. Tzelepis, G. Hodgson, D. Grail, A. R. Dunn, and I. Bertoncello. 1995. Granulocytemacrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood 86: 66-72.
54. Lin, H., E. Lee, K. Hestir, C. Leo, M. Huang, E. Bosch, R. Halenbeck, G. Wu, A. Zhou, D. Behrens, et al. 2008. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320: 807-811. (Pubitemid 351929632)
55. Suzu, S., N. Yanai, Y. Sato-Somoto, M. Yamada, T. Kawashima, T. Hanamura, N. Nagata, F. Takaku, and K. Motoyoshi. 1991. Characterization of macrophage colony-stimulating factor in body fluids by immunoblot analysis. Blood 77: 2160-2165.
56. Porcheray, F., S. Viaud, A. C. Rimaniol, C. Léone, B. Samah, N. DereuddreBosquet, D. Dormont, and G. Gras. 2005. Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142: 481-489. (Pubitemid 41719844)
57. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
58. Racke, F. K., K. Lewandowska, S. Goueli, and A. N. Goldfarb. 1997. Sustained activation of the extracellular signal-regulated kinase/mitogen- activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J. Biol. Chem. 272: 23366-23370. (Pubitemid 27392477)
59. Valledor, A. F., L. Arpa, E. Sánchez-Tilló, M. Comalada, C. Casals, J. Xaus, C. Caelles, J. Lloberas, and A. Celada. 2008. IFN-γ-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation. Blood 112: 3274-3282.
60. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11: 936-944.
61. H17 responses. Nat. Immunol. 12: 231-238.
62. Gerlach, H., V. Laumann, S. Martens, C. F. Becker, R. S. Goody, and M. Geyer. 2010. HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nat. Chem. Biol. 6: 46-53.
63. Trible, R. P., L. Emert-Sedlak, and T. E. Smithgall. 2006. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction. J. Biol. Chem. 281: 27029-27038. (Pubitemid 44401731)
64. Dikeakos, J. D., K. M. Atkins, L. Thomas, L. Emert-Sedlak, I. J. Byeon, J. Jung, J. Ahn, M. D. Wortman, B. Kukull, M. Saito, et al. 2010. Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol. Biol. Cell 21: 3279-3292.
65. Krautkrämer, E., S. I. Giese, J. E. Gasteier, W. Muranyi, and O. T. Fackler. 2004. Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 78: 4085-4097. (Pubitemid 38437215)
66. Mangino, G., Z. A. Percario, G. Fiorucci, G. Vaccari, F. Acconcia, C. Chiarabelli, S. Leone, A. Noto, F. A. Horenkamp, S. Manrique, et al. 2011. HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS ONE 6: e22982.